Sotera Health (NASDAQ:SHC) Announces Earnings Results

Sotera Health (NASDAQ:SHC) issued its earnings results on Monday. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.04, Briefing.com reports. Sotera Health had a net margin of 5.09% and a return on equity of 48.47%. The business had revenue of $277.00 million for the quarter, compared to analyst estimates of $266.45 million. During the same period in the previous year, the business earned $0.19 EPS. The firm’s revenue was up 8.6% on a year-over-year basis. Sotera Health updated its FY24 guidance to $0.67-$0.75 EPS and its FY 2024 guidance to 0.670-0.750 EPS.

Sotera Health Stock Performance

Shares of SHC traded up $0.28 during mid-day trading on Thursday, hitting $14.67. 821,828 shares of the company’s stock were exchanged, compared to its average volume of 1,339,469. The company has a quick ratio of 2.86, a current ratio of 3.20 and a debt-to-equity ratio of 5.39. The firm has a market cap of $4.15 billion, a price-to-earnings ratio of 77.21 and a beta of 2.06. The stock’s 50-day simple moving average is $12.40 and its 200-day simple moving average is $12.85. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research note on Tuesday. Barclays raised their target price on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, Piper Sandler started coverage on shares of Sotera Health in a research note on Tuesday, May 21st. They issued a “neutral” rating and a $13.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $15.70.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.